TFS CAPITAL LLC - ARALEZ PHARMACEUTICALS INC ownership

ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 94 filers reported holding ARALEZ PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of ARALEZ PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$97,000
+47.0%
71,556
+376.1%
0.04%
+111.1%
Q4 2016$66,000
-92.6%
15,031
-94.0%
0.02%
-85.9%
Q1 2016$891,000250,9690.13%
Other shareholders
ARALEZ PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
JW Asset Management, LLC 2,737,140$9,033,0007.18%
DRILL CRAIG A 584,600$1,929,0003.80%
ARMISTICE CAPITAL, LLC 2,664,000$8,791,0003.35%
Healthcare Value Capital, LLC 575,000$1,898,0002.30%
Tiger Legatus Capital Management, LLC 1,500,000$4,950,0001.50%
Broadfin Capital, LLC 4,106,990$13,553,0001.32%
Kavi Asset Management, LP 313,627$1,035,0000.83%
Elk Creek Partners, LLC 1,514,918$4,999,0000.36%
Par Capital Management 6,400,000$21,120,0000.35%
Healthcare Value Capital, LLC 75,000$248,0000.30%
View complete list of ARALEZ PHARMACEUTICALS INC shareholders